(Q52535430)

2 May 2018

title

Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall. (English)

1 reference

2 May 2018

1 reference

Maria Alexandra Brito

series ordinal

1 reference

2 May 2018

author name string

Maria Margarida Tenreiro

series ordinal

1 reference

2 May 2018

Maria Leonor Correia

series ordinal

1 reference

2 May 2018

publication date

24 August 2017

1 reference

2 May 2018

published in

Angiogenesis

1 reference

2 May 2018

volume

1 reference

2 May 2018

issue

1 reference

2 May 2018

page(s)

443-462

1 reference

2 May 2018

Regulation of hematopoietic stem cells by bone marrow stromal cells

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Blood flow to the haemopoietic bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Angiogenesis and Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cells and integrins: adhesive needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow stromal cells as immunomodulators. A primer for dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Immunological dysregulation in multiple myeloma microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Biology of BM failure syndromes: role of microenvironment and niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Osteoblastic and vascular endothelial niches, their control on normal hematopoietic stem cells, and their consequences on the development of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Detection of functional haematopoietic stem cell niche using real-time imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Mesenchymal stem cells in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The Key Role of the Blood Supply to Bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Distinct bone marrow blood vessels differentially regulate haematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Arteriolar niches maintain haematopoietic stem cell quiescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Neurovascular unit: a focus on pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Extracellular matrix remodeling in the vascular wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Cellular and molecular mechanisms underlying blood vessel lumen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Mechanisms of normal and tumor-derived angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Biological aspects of angiogenesis in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Role of endothelial progenitor cells in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Cellular response of the blood-brain barrier to injury: Potential biomarkers and therapeutic targets for brain regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cells, angioblasts, and angiogenesis--old terms reconsidered from a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Human endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cells for postnatal vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Transcriptional control of endothelial cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Culture and identification of endothelial progenitor cells from human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

21 January 2018

AC133/CD133/Prominin-1

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

PECAM-1, a key player in neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The role of selectins in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CD117(+) amniotic fluid stem cells: state of the art and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CD14 polymorphisms, microbial exposure and allergic diseases: a systematic review of gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Blood monocytes mimic endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cells--an evolving story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone markers in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

IMWG consensus on risk stratification in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Smoldering multiple myeloma: to treat or not to treat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

How I treat multiple myeloma in younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Myeloma bone disease: pathogenesis, current treatments and future targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Adverse prognostic impact of bone marrow microvessel density in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow angiogenesis and progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow microenvironment in multiple myeloma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Angiogenic Activity of Mesenchymal Stem Cells in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Targeting vasculogenesis to prevent progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: Association with disease characteristics and variation in different cell compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Changes in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Matrix metalloproteinases in stem cell regulation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Bone marrow vascular niche and the control of angiogenesis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CXCR4 inhibitors: tumor vasculature and therapeutic challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Production of stromal cell-derived factor-1 (SDF-1)and expression of CXCR4 in human bone marrow endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a/CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The role of eNOS in the migration and proliferation of bone-marrow derived endothelial progenitor cells and in vitro angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Plasma levels of osteopontin and vascular endothelial growth factor in association with clinical features and parameters of tumor burden in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα-p38-SP-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cells: isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The extracellular matrix at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The effect of CXCL12 on endothelial progenitor cells: potential target for angiogenesis in intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The PDGF family: four gene products form five dimeric isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Hematopoietic Stem Cell Niche: Role in Normal and Malignant Hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

Expression of VEGF and its receptors by myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-017-9571-8

10.1007/S10456-017-9571-8

21 January 2018

Identifiers

DOI

1 reference

2 May 2018

release_wevltzeyczbxfbeqx66ggosu2q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wevltzeyczbxfbeqx66ggosu2q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

2 May 2018